Aufgrund von Wartungsarbeiten steht JLUpub am 18.05.2026 von 8:00 Uhr bis vorraussichtlich 11:00 Uhr nicht zur Verfügung.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Due to maintenance work, JLUpub will be unavailable on 18 May 2026 from 8.00 am until approximately 11.00 am.

The significance of glutaredoxins for diabetes mellitus and its complications

dc.contributor.authorZhou, Mengmeng
dc.contributor.authorHanschmann, Eva-Maria
dc.contributor.authorRömer, Axel
dc.contributor.authorLinn, Thomas
dc.contributor.authorPetry, Sebastian Friedrich
dc.date.accessioned2024-11-18T15:15:39Z
dc.date.available2024-11-18T15:15:39Z
dc.date.issued2024
dc.description.abstractDiabetes mellitus is a non-communicable metabolic disease hallmarked by chronic hyperglycemia caused by beta-cell failure. Diabetic complications affect the vasculature and result in macro- and microangiopathies, which account for a significantly increased morbidity and mortality. The rising incidence and prevalence of diabetes is a major global health burden. There are no feasible strategies for beta-cell preservation available in daily clinical practice. Therefore, patients rely on antidiabetic drugs or the application of exogenous insulin. Glutaredoxins (Grxs) are ubiquitously expressed and highly conserved members of the thioredoxin family of proteins. They have specific functions in redox-mediated signal transduction, iron homeostasis and biosynthesis of iron-sulfur (FeS) proteins, and the regulation of cell proliferation, survival, and function. The involvement of Grxs in chronic diseases has been a topic of research for several decades, suggesting them as therapeutic targets. Little is known about their role in diabetes and its complications. Therefore, this review summarizes the available literature on the significance of Grxs in diabetes and its complications. In conclusion, Grxs are differentially expressed in the endocrine pancreas and in tissues affected by diabetic complications, such as the heart, the kidneys, the eye, and the vasculature. They are involved in several pathways essential for insulin signaling, metabolic inflammation, glucose and fatty acid uptake and processing, cell survival, and iron and mitochondrial metabolism. Most studies describe significant changes in glutaredoxin expression and/or activity in response to the diabetic metabolism. In general, mitigated levels of Grxs are associated with oxidative distress, cell damage, and even cell death. The induced overexpression is considered a potential part of the cellular stress-response, counteracting oxidative distress and exerting beneficial impact on cell function such as insulin secretion, cytokine expression, and enzyme activity.en
dc.identifier.urihttps://jlupub.ub.uni-giessen.de/handle/jlupub/19832
dc.identifier.urihttps://doi.org/10.22029/jlupub-19188
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddcddc:610
dc.titleThe significance of glutaredoxins for diabetes mellitus and its complications
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.articlenumber103043
local.source.epage18
local.source.journaltitleRedox Biology
local.source.spage1
local.source.urihttps://doi.org/10.1016/j.redox.2024.103043
local.source.volume71

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.1016_j.redox.2024.103043.pdf
Size:
2.9 MB
Format:
Adobe Portable Document Format